Arrhythmias & electrophysiology

The Relevance of the Type of Ventricular Arrhythmia in Titin-Related Dilated Cardiomyopathy: A Multicenter Study

JACC Clin ElectrophysiolPublished Multicenter study of TTNtv carriers referred for ablation

Authors' conclusion

In TTNtv carriers, SMVTs but not frequent PVCs are associated with high mortality due to heart failure. Occurrence of SMVT may identify a subgroup at risk for rapid, progressive adverse remodeling. The prognostic significance of different VA subtypes needs to be confirmed in a larger cohort.

Study context

Population
Truncating titin variant (TTNtv) carriers referred for ablation of sustained monomorphic VT (SMVT) or frequent premature ventricular complexes (PVCs)TTNtv carriers referred for ablation · SMVT 14 · frequent PVCs 8
Participants
Twenty-two participants
Comparison
SMVT vs frequent PVCs among TTNtv carriers
  • SMVTn = 14
  • PVCn = 8
Outcome
NSVT cycle length
Methodological details5 centers
  • 5 centers

Main finding

As reported in the abstract

Further findings

Substrate location

SMVT substrates extended in a basal ring-like fashion with septal predominance; PVC sites of origin limited to the basal anterior left ventricular segment

Procedural success and follow-up outcomes, SMVT group

Acute complete procedural success
36%
Recurrent VT
86%
Died of progressive heart failure
50%

Procedural success and follow-up outcomes, PVC group

Complete abolition of PVCs
13%
Median PVC burden at 3 months
1%
No deaths or sustained VT during follow-up

Association with mortality and VT-free survival

Ventricular arrhythmia (VA) subtype and nonsustained ventricular tachycardia (NSVT) cycle length were associated with mortality and poor VT-free survival

Follow-up

Median follow-up
44 months

Original publication

The Relevance of the Type of Ventricular Arrhythmia in Titin-Related Dilated Cardiomyopathy: A Multicenter Study. JACC Clin Electrophysiol. Published 12 March 2025. doi:10.1016/j.jacep.2025.01.010

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.